| Literature DB >> 26475601 |
Horst Christian Vollmar1,2, Thomas Ostermann3, Marcus Redaèlli4,5.
Abstract
BACKGROUND: The scenario technique is a method for future research and for strategic planning. Today, it includes both qualitative and quantitative elements. The aims of this scoping review are to give an overview of the application of the scenario method in the fields of health care and to make suggestions for better reporting in future scenario projects.Entities:
Mesh:
Year: 2015 PMID: 26475601 PMCID: PMC4609149 DOI: 10.1186/s12874-015-0083-1
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Flow chart of the review process
Subjects of the scenario projects
| Year of publication | Reference | Institution | Country | Focus/title of the project | Time horizon [approx. in years] | Number of scenarios |
|---|---|---|---|---|---|---|
| Before 1995 | ||||||
| 2 x 1988 | Becker [ | STGb | Netherlands | Aging in the Netherlands | 10 | 3 |
| 1991, 1992 | Bijl [ | STGb | Netherlands | Dementia in the Netherlands | 10 | 3 |
| 1994 | Leufkens et al. [ | STGb | Netherlands | Future of Medicine | 10 (15) | 4 |
| 1988, 1989 | Schaapveld & Cleton [ | STGb | Netherlands | Cancer diseases in the Netherlands | 15 | >5 |
| 1988 | Schreuder [ | STGb | Netherlands | Cardio-vascular diseases in the Netherlands | 15 | 19 |
| 1989, 1997 | Van Beeck et al.[ | STGb | Netherlands | Accident mortality and unintentional injuries in the Netherlands | 15 | 9 |
| 1992 | Bezold [ | IAFa | US | Leadership practices and organizational demands | 10 | 5 |
| 1993 | Venable et al. [ | University of Alabama | US | Local public health departments | 5 | 2 |
| 1991 | Zentner [ | Institute for Health Care Marketing | US | Health care organization (case example: future opportunities of American Transitional Care, Inc.) | 10 | 3 |
| 1995-2004 | ||||||
| 2001 | Harmsen et al. [ | Aarhus School of Business | Denmark | Danish food industry | 10 | 3 |
| 1999 | Islei et al. [ | Various universities | UK | Pharmaceutical industry | n.s.c | 7 |
| 1997 | Leufkens et al. [ | Department of Pharmaco-epidemiology & Pharmacotherapy | Netherlands | Clinical pharmacy | n.s.c | 3 |
| 2000 | Ling & Hadridge [ | Cambridge Foresight | UK | Health care | (15-) 20 | 2 |
| 2004 | Neiner et al. [ | National Center for Chronic Disease Prevention and Health Promotion | US | Public health (specifically to illustrate a health department’s desire to address chronic disease prevention and control) | n.s.c | 3 |
| 1998 | Nielsen [ | Allen Memorial Hospital | US | Healthcare delivery | 10 | 1 |
| 2001 | Sager [ | Life Science Strategy Consulting | US | Biotechnology | n.s.c | 4 |
| 2003 | Van Lente et al. [ | University of Utrecht | Netherlands | Biotechnology in Europe | 10-15 | 4 |
| Since 2005 | ||||||
| 2005 | Bezold [ | IAFa/Picker Institute | US | Patient-centered care | 10 | 4 |
| 2005 | Bezold & Beck [ | IAFa | US | Drug regulation | 50 | 3 |
| 2011 | Bierbooms et al. [ | Tilburg University | Netherlands | What types of residence should be organized for people with mental health problems? | 5 | 4 |
| 2012 | Buchan & Seccombe [ | Queen Margaret University | UK | Future supply of registered nursing staff, midwives and health visitors in the National Health Service (NHS) | 10 | 8 |
| 2013 | Carlsen et al. [ | Defense Research Agency | Sweden | Local adaptation to climate change (health aspects) | 20 | 2 |
| 2 x 2005 | Clark et al. [ | International Campaign to Revitalise Academic Medicine (ICRAM) | International | Academic medicine | 20 | 5 |
| 2006 | Eberl & Schnepp [ | The German Nurses Association | Germany | Family health nursing in Germany | n.s.c | 7 reduced to 5 |
| 2011 | Enzmann et al. [ | Society of Chairs of Academic Radiology Departments (SCARD) | US | Field of radiology | 10 | 3 |
| 2012 | Gnatzy & Moser [ | EBS Business School, Deutschland | India (Germany) | Evolving health insurance industry in rural India | 10 | 4 |
| 2014 | Gregório et al. [ | WHO Collaborating Centre for Health Workforce Policy and Planning | Portugal | Community pharmacists | 10 | 3 |
| 2013 | Karger [ | Forschungs-zentrum Jülich | Germany | Personalized medicine on the example of dementia | 20 | 4 |
| 2006 | Ma & Seid [ | RAND cooperation | US | Disease management in the US | 15 | 8 |
| 2009 | Meristö [ | My wellbeing project | Finland | Life control especially related to health and personal wellbeing using ICT-tools | n.s.c | 3 |
| 2014 | Nguyen et al. [ | Centre for Public Health and Ecosystem Research | Vietnam | Community development | 10 | 2d |
| 2005 | Niewöhner et al. [ | Max-Delbrueck-Center for Molecular Medicine (MDC) | Germany | Relationship between biomedicine and economy in Germany | 10 | 4 |
| 2012 | Retèl et al. [ | Netherlands Cancer Institute | Netherlands | Developments in technology assessment (e.g. clinical implementation of the 70-gene signature for breast cancer) | 15 | 10 reduced to 5 |
| 2012 | Rhea & Bettles [ | Academy of Nutrition & Dietetics | US | Dietetics workforce supply and demand | 10 | 4 |
| 2006 | Rydström & Törnberg [ | Karolinska Institute | Sweden | External influences on cervical cancer incidence and mortality | n.s.c | 8 |
| 2011 | Suk & Semenza [ | European Centre for Disease Prevention and Control (ECDC) | Europe (Sweden) | Future infectious disease threats to Europe | 10 | 8 |
| 2014 | Vollmar et al. [ | German Center for Neuro-degenerative Diseases (DZNE) | Germany | Health care for people with dementia in Germany | 20 | 5 |
| 2008 | Wiek et al. [ | Institute for Environmental Decisions (IED) | Switzerland | Possible future developments of nanotechnology in Switzerland | 10 | 5 |
a IAF Institute for Alternative Futures, b STG Steering Committee on Future Health Scenarios, c n.s. not specified d“the outputs were limited to the best and worst case scenarios” [30]
Proposed key methodological criteria to report in scenario projects
| Criteria |
|---|
| Aim of the scenario project |
| • Does the word “scenario project (planning, approach…)” appear in the title along with the topic of primary interest? |
| • Is the topic of interest clearly described? |
| • What are the proposed implications? |
| • Are the target groups and/or stakeholders specified? |
| • Is there a clear time horizon? |
| Framework of the scenario project |
| • Are the preconditions and presuppositions well described? |
| • Is the process of developing the areas of influence, key factors, and future projections adequately described? |
| • Who is involved (description of scenario development team and participants/experts)? |
| • Is the background of participants/experts clear? |
| • How will participants/experts be selected or excluded? |
| Methodological approach of the scenario project |
| • Is the specific scenario technique used (e.g. only narrative, consistence analysis, cross-impact analysis) well described? |
| • If any, is the mathematical approach well described? |
| • How is the mathematical approach transformed/implemented in software (if applicable)? |
| • Is there any combination with other methods like the Delphi technique? |
| • Is the presentation of the scenario development process adequate? |
| • Are the scenarios presented in a sound manner (to the specified target groups/stakeholders)? |
| Impact of the scenario project |
| • Are there any recommendations for different target groups/stakeholders? |
| • What are the next steps after the scenario project? |